Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$2.6 - $5.12 $85,152 - $167,685
32,751 New
32,751 $94,000
Q2 2022

Aug 12, 2022

SELL
$2.19 - $3.98 $41,038 - $74,581
-18,739 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$3.28 - $7.12 $9,587 - $20,811
2,923 Added 18.48%
18,739 $72,000
Q4 2021

Feb 11, 2022

SELL
$6.55 - $13.25 $181,985 - $368,138
-27,784 Reduced 63.72%
15,816 $105,000
Q3 2021

Nov 12, 2021

BUY
$7.29 - $11.0 $317,844 - $479,600
43,600 New
43,600 $395,000

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $158M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.